Showing results (841-850 of 870) with videos related to

Sort By:
Pageof 87
Water Research|February 28, 2012
Spatial and temporal variation in indicator microbe sampling is influential in beach management decisionsAmber A Enns, Laura J Vogel, Amir M Abdelzaher, et al.
Ambio|September 23, 2015
Molecular tools for bathing water assessment in Europe: Balancing social science research with a rapidly developing environmental science evidence-baseDavid M Oliver, Nick D Hanley, Melanie van Niekerk, et al.
JAMA|May 4, 2016
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011Katherine E Fleming-Dutra, Adam L Hersh, Daniel J Shapiro, et al.
Annals of Global Health|July 15, 2024
Enhancing Human Health and Wellbeing through Sustainably and Equitably Unlocking a Healthy Ocean's PotentialLora E Fleming, Philip J Landrigan, Oliver S Ashford, et al.
Scientific Reports|May 19, 2025
Independent and interactive effects of disease and methylmercury on demographic rates across multiple amphibian populationsMorgan P Kain, Blake R Hossack, Kelly L Smalling, et al.
Hospital Pediatrics|January 25, 2022
National Healthcare Safety Network 2018 Baseline Neonatal Standardized Antimicrobial Administration RatiosErin N O'Leary, Jonathan R Edwards, Arjun Srinivasan, et al.
Journal of Water and Health|October 7, 2011
Daily measures of microbes and human health at a non-point source marine beachAmir M Abdelzaher, Mary E Wright, Cristina Ortega, et al.
Vaccine|January 4, 2025
A framework for monitoring RSV prevention product effectiveness in the United StatesLauren E Roper, Ruth Link-Gelles, Diya Surie, et al.
MMWR. Morbidity and Mortality Weekly Report|August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
Pageof 87